Starten Sie Ihre Suche...


Wir weisen darauf hin, dass wir technisch notwendige Cookies verwenden. Weitere Informationen
Publikationen
Ergebnisse pro Seite:  10

Mehnert-Theuerkauf, Anja; Faller, Hermann; Herschbach, Peter et al.

Psycho-oncological care needs in cancer centers

ONKOLOGE. Bd. 26. H. 2. 2020 S. 178-184


Hempler, I.; Riccetti, N.; Hermes-Moll, K. et al.

Psycho-oncological care of cancer patients with a migration background ("POM Study") - First results of the qualitative interviews

ONCOLOGY RESEARCH AND TREATMENT. Bd. 43. H. SUPPL 4. 2020 S. 226-226


Koller, Michael; Shamieh, Omar; Hjermstad, Marianne J. et al.

Psychometric properties of the updated EORTC module for assessing quality of life in patients with lung cancer (QLQ-LC29): an international, observational field study

LANCET ONCOLOGY. Bd. 21. H. 5. 2020 S. 723-732


Butsch, C. S.; Heider, J.; Brockmann, M. A. et al.

Pulsatile Tumor of the Orbit

OPHTHALMOLOGE. 2020


Nestle, Ursula; Adebahr, Sonja; Kaier, Klaus et al.

Quality of life after pulmonary stereotactic fractionated radiotherapy (SBRT): Results of the phase II STRIPE trial

RADIOTHERAPY AND ONCOLOGY. Bd. 148. 2020 S. 82-88


Buettner, Matthias; Hinz, Andreas; Singer, Susanne et al.

Quality of life of patients more than 1 year after surgery for thyroid cancer

HORMONES-INTERNATIONAL JOURNAL OF ENDOCRINOLOGY AND METABOLISM. 2020


Zahnreich, Sebastian; Roesler, Hans-Peter; Schwanbeck, Carina et al.

Radiation-induced DNA double-strand breaks in peripheral leukocytes and therapeutic response of heel spur patients treated by orthovoltage X-rays or a linear accelerator

STRAHLENTHERAPIE UND ONKOLOGIE. Bd. 196. H. 12. 2020 S. 1116-1127


Rades, Dirk; Bartscht, Tobias; Hunold, Peter et al.

Radiochemotherapy with or without cetuximab for unresectable esophageal cancer: final results of a randomized phase 2 trial (LEOPARD-2)

STRAHLENTHERAPIE UND ONKOLOGIE. Bd. 196. H. 9. 2020 S. 795-804


Kudo, Masatoshi; Galle, Peter R.; Llovet, Josep M. et al.

Ramucirumab in elderly patients with hepatocellular carcinoma and elevated alpha-fetoprotein after sorafenib in REACH and REACH-2

LIVER INTERNATIONAL. Bd. 40. H. 8. 2020 S. 2008-2020


Zhu, Andrew X.; Ikeda, Masafumi; Galle, Peter R. et al.

Ramucirumab in patients with advanced HCC and elevated alpha-fetoprotein (AFP): Outcomes by treatment-emergent ascites.

JOURNAL OF CLINICAL ONCOLOGY. Bd. 38. H. 15. 2020